Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
***2023: Top 10 U.S. Biopharma Clusters_ genengnews
2022: Top 10 U.S. Biopharma Clusters
*Industry: Philadephia, Pennsylvania

TetraLogic Pharmaceuticals

Parents

Amount: $23M Round: Series C Investor(s) Pfizer Venture Investments, Quaker BioVentures, Vertical Group, Hatteras Venture Partners, Novitas Capital, HealthcareVentures, Pfizer Venture, Clarus Ventures, Latterrell Venture Partners, Amgen Ventures
Focused on discovery and development of drugs to treat cancer through drugs that unblock the cell death or apoptosis pathway, resulting in the death of tumor cells.
Industry: Pharmaceuticals / Drugs Sub-Industry: N/A
It's under investigation as a single agent in patients with hard-to-treat solid tumors and lymphoma.
Malvern, Pennsylvania
TetraLogic - Top 15 Biotech VC Deals of 2010
TetraLogic has been gathering funding to support the development of early-stage cancer drug TL32711, a SMAC mimetic designed to neutralize the activity of an inhibitor of apoptosis proteins, which block tumor cell death.
TetraLogic Pharmaceuticals is a privately held company focused on the discovery and development of important drugs to treat cancer.
TetraLogic pushes Series C to $37M (2010)